Maximize the profitability of your ophthalmology products by capitalizing on pricing and reimbursement opportunities
New products for major ophthalmology indications have to be established in treatment pathways dominated by non-drug interventions such as laser treatment and surgery.
We have extensive experience in advising clients on how to demonstrate product value to a wide range of stakeholders, including patients, providers, and local and national payers.
Cutting-edge solutions and creative recommendations for ophthalmology reimbursement and market access
Examples of the disease areas we have worked in include:
- diabetic macular edema
- dry eye
- glaucoma.
You can work with us at an early stage in the development of your ophthalmology product to establish your pricing, reimbursement, and market access strategy; or you can benefit from guidance throughout the whole process with evidence generation, evidence synthesis, and communication. If you have one-off challenges, our expert team is able to address those as well.
Request a call
